Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday, December 13, 2004 | ENZO Biochem Reports Fiscal 2005 First Quarter Operating Results and Sequential Gains |
Wednesday, December 08, 2004 | Discussion of Fiscal 2005 First Quarter Operating Results |
Thursday, November 11, 2004 | ENZO Life Sciences Launches New Advanced Amplification Technology for Gene Expression Analysis Studies |
Monday, November 01, 2004 | ENZO Biochem Presents Five Papers Covering Pre-Clinical Research Results At Liver Disease Conference |
Thursday, October 14, 2004 | ENZO Biochem Announces Settlement Agreement With Digene Corporation For Payments In Excess Of $30.5 Million |
Thursday, October 14, 2004 | ENZO Biochem Reports Operating Results |
Thursday, October 07, 2004 | ENZO Biochem Declares 5% Stock Dividend |
Wednesday, September 29, 2004 | ENZO Biochem Reports Phase II Data of Alequel™ for Management of Crohn’s Disease Trial Successfully |
Friday, September 24, 2004 | ENZO Biochem to Present At 2004 UBS Global Life Sciences Conference |
Wednesday, July 28, 2004 | ENZO Biochem Reports Court Ruling |
Tuesday, July 20, 2004 | ENZO Biochem Announces Supply And License Agreement With GlaxoSmithKline |
Wednesday, July 14, 2004 | ENZO Biochem Appoints Marcus A. Conant, M.D. To Its Board Of Directors |
Monday, June 14, 2004 | ENZO Biochem Granted European Patent For Displacer Technology To Treat Gene Abnormalities |
Monday, June 14, 2004 | ENZO Biochem Reports Results for Fiscal 2004 Third Quarter |
Thursday, June 10, 2004 | ENZO Biochem to Present at Needham & Company Third Annual Biotechnology Conference |
Tuesday, June 08, 2004 | ENZO Biochem, Inc. Files Patent Infringement Lawsuit Involving Dna Sequencing Against Applera Corp. and Subsidiary |
Tuesday, June 08, 2004 | ENZO Biochem’s Subsidiary Issued United States Patent Relating To Methods Of Nucleic Acid Amplification |
Thursday, June 03, 2004 | ENZO Rejects Roche Settlement Offer Roche Responds With Lawsuit |
Thursday, May 20, 2004 | ENZO Biochem to Begin Clinical Trial on New Immunomodulatory Agent |
Monday, May 17, 2004 | ENZO Biochem Presenting Preclinical Data On Compound For Treating Immune Mediated Disorders |
Wednesday, April 21, 2004 | ENZO Biochem, University of Connecticut Enter Exclusive Licensing Agreements for Development of Novel Therapeutics to Spur Bone Growth |
Tuesday, March 23, 2004 | ENZO Biochem Reports on Preclinical Study That Points To Development of New Compound For Treating Immune Mediated Diseases |
Tuesday, March 16, 2004 | ENZO Biochem Reports Operating Results For Fiscal 2004 Second Quarter |
Thursday, March 11, 2004 | ENZO Biochem Reports Interim Results for Clinical Trial of Alequel™, Its Investigational Treatment for Management of Crohn’s Disease |
Thursday, February 26, 2004 | ENZO Biochem Acquires Assets of Oragen Corporation, a Biotech Firm Involved In Immune Regulation |
Wednesday, January 14, 2004 | Phase I/II Hiv Gene Therapy Trial Initiated Enzo Biochem Tells Annual Meeting |